BACKGROUND: The genetic determinants of sporadic renal cell cancer (RCC) are largely unknown. Previous studies have suggested associations between ABO blood group and risk of various cancers. However, its relationship to RCC remains unclear and no prospective data are available. METHODS: We prospectively followed up 77,242 women in the Nurses' Health Study and 30,071 men in the Health Professionals Follow-Up Study from 1996 to 2008. The information on the ABO blood group was collected from participants' self-reports in 1996. Incidence of pathology-confirmed RCC was compared using hazard ratios (HRs) and 95% confidence intervals (CIs) derived from Cox proportional hazards models. RESULTS: During 12 years of follow-up, 163 cases of incident RCC were documented in women and 88 cases in men. The multivariate HRs between non-O blood group (combined group of A, AB, and B) vs. blood group O were 1.51 (95% CI 1.09-2.09) in women, 1.08 (95% CI 0.70-1.66) in men, and 1.32 (95% CI 0.95-1.82) in the pooled cohorts. The associations between ABO blood group and RCC were consistent across strata of known risk factors for RCC including age, obesity, smoking, and history of hypertension (Pinteraction ≥ 0.32). CONCLUSIONS: We found a suggestive non-significant association between non-O blood group and increased risk of RCC in the pooled cohorts of men and women, and this association was significant in women. Our findings need to be replicated by other prospective studies.
BACKGROUND: The genetic determinants of sporadic renal cell cancer (RCC) are largely unknown. Previous studies have suggested associations between ABO blood group and risk of various cancers. However, its relationship to RCC remains unclear and no prospective data are available. METHODS: We prospectively followed up 77,242 women in the Nurses' Health Study and 30,071 men in the Health Professionals Follow-Up Study from 1996 to 2008. The information on the ABO blood group was collected from participants' self-reports in 1996. Incidence of pathology-confirmed RCC was compared using hazard ratios (HRs) and 95% confidence intervals (CIs) derived from Cox proportional hazards models. RESULTS: During 12 years of follow-up, 163 cases of incident RCC were documented in women and 88 cases in men. The multivariate HRs between non-O blood group (combined group of A, AB, and B) vs. blood group O were 1.51 (95% CI 1.09-2.09) in women, 1.08 (95% CI 0.70-1.66) in men, and 1.32 (95% CI 0.95-1.82) in the pooled cohorts. The associations between ABO blood group and RCC were consistent across strata of known risk factors for RCC including age, obesity, smoking, and history of hypertension (Pinteraction ≥ 0.32). CONCLUSIONS: We found a suggestive non-significant association between non-O blood group and increased risk of RCC in the pooled cohorts of men and women, and this association was significant in women. Our findings need to be replicated by other prospective studies.
Authors: Simona Iodice; Patrick Maisonneuve; Edoardo Botteri; Maria Teresa Sandri; Albert B Lowenfels Journal: Eur J Cancer Date: 2010-12 Impact factor: 9.162
Authors: Margaret A Gates; Brian M Wolpin; Daniel W Cramer; Susan E Hankinson; Shelley S Tworoger Journal: Int J Cancer Date: 2010-03-22 Impact factor: 7.396
Authors: Brian M Wolpin; Andrew T Chan; Patricia Hartge; Stephen J Chanock; Peter Kraft; David J Hunter; Edward L Giovannucci; Charles S Fuchs Journal: J Natl Cancer Inst Date: 2009-03-10 Impact factor: 13.506
Authors: S Zouine; F Marnissi; N Otmani; M Bennani Othmani; M El Wafi; K Kojok; Y Zaid; N Tahiri Jouti; N Habti Journal: Med Oncol Date: 2016-05-30 Impact factor: 3.064
Authors: Malik Tariq Rasool; Ashfaq Hafiz; Saquib Zaffar Banday; Ishtiyaq Ahmad Dar; Shareefa Akhter; Mohd Zubair Qureshi; Sajad Geelani; Nazir Ahmad Dar Journal: J Gastrointest Cancer Date: 2021-06
Authors: Sarah C Markt; Irene M Shui; Robert H Unger; Yuksel Urun; Christine D Berg; Amanda Black; Paul Brennan; H Bas Bueno-de-Mesquita; Susan M Gapstur; Edward Giovannucci; Christopher Haiman; Brian Henderson; Robert N Hoover; David J Hunter; Timothy J Key; Kay-Tee Khaw; Federico Canzian; Nerea Larranga; Loic Le Marchand; Jing Ma; Alessio Naccarati; Afshan Siddiq; Meir J Stampfer; Par Stattin; Victoria L Stevens; Daniel O Stram; Anne Tjønneland; Ruth C Travis; Dimitrios Trichopoulos; Regina G Ziegler; Sara Lindstrom; Peter Kraft; Lorelei A Mucci; Toni K Choueiri; Kathryn M Wilson Journal: Prostate Date: 2015-08-13 Impact factor: 4.104